Basic Information | Post buying leads | Suppliers |
Name |
Habekacin |
EINECS | N/A |
CAS No. | 104931-87-5 | Density | g/cm3 |
PSA | 300.76000 | LogP | -2.05760 |
Solubility | N/A | Melting Point |
N/A |
Formula | C22H44N6O10•xH2O4S | Boiling Point | 904°Cat760mmHg |
Molecular Weight | 650.7 | Flash Point | 500.5°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intravenous and intramuscular routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and SOx | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
(s)-oxobutyl)-2-deoxysulfate(salt);6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-n’-(4-amino-2-hydroxy-1-4;arbekacinsulfate;d-streptamine,o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,;ARBEKACIN SULPHATE;D-Streptamine, O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-D-erythro-hexopyranosyl-(1→4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-, sulfate (salt);HBK |
IUPAC Name: (2S)-4-Amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide; sulfuric acid
CAS: 104931-87-5
The Molecular formula of Habekacin (CAS NO.104931-87-5): C22H46N6O14S
Molecular Weight: 650.7
The Molecular Structure of Habekacin (CAS NO.104931-87-5):
Flash Point: 500.5 °C
Enthalpy of Vaporization: 149.21 kJ/mol
Boiling Point: 904 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°C
1. | ivn-rat LD50:150 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),7473. | ||
2. | ipr-mus LD50:540 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),7473. | ||
3. | scu-mus LD50:476 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),7473. | ||
4. | ivn-mus LD50:82,300 µg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),7473. | ||
5. | ims-mus LD50:372 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),7473. | ||
6. | ivn-dog LDLo:150 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),7587. | ||
7. | ims-dog LDLo:400 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 20 (1986),7587. |
Poison by intravenous and intramuscular routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and SOx
Habekacin with CAS number of 104931-87-5 is also known as (s)-Oxobutyl)-2-deoxysulfate(salt) ; 6-Tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-n’-(4-amino-2-hydroxy-1-4 ; Arbekacinsulfate ; D-streptamine,o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2, ; Arbekacin sulphate ; D-Streptamine, O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-D-erythro-hexopyranosyl-(1→4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-, sulfate (salt) ; HBK .